APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Cell Banking Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Immune Cell Banking Service Market Analysis and Forecast 2026-2032

2 May 2026257 pages

Choose your research edition.

Industry ResearchImmune Cell Banking Service Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Cell Banking Service Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Immune Cell Banking Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Cell Banking Service Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Cell Banking Service Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global Immune Cell Banking Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Immune Cell Banking Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Immune Cell Banking Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Immune Cell Banking Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Immune Cell Banking Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Immune Cell Banking Service include HealthBanks, BioLife Solutions, Sartorius, ThermoGenesis, Charles River, Biorep Technologies, Cryo-Cell International, CGT GLOBAL and Cordlife Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Immune Cell Banking Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immune Cell Banking Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Immune Cell Banking Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune Cell Banking Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immune Cell Banking Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Immune Cell Banking Service revenue, projected growth trends, production technology, application and end-user industry.

Immune Cell Banking Service Segment by Company

HealthBanks

BioLife Solutions

Sartorius

ThermoGenesis

Charles River

Biorep Technologies

Cryo-Cell International

CGT GLOBAL

Cordlife Group

Celularity

Boyalife

Beike Biotechnology

Forever Labs

Redermis

LifeCell International

VCANBIO

BGI Group

Shanghai Cell Therapy Group

Immune Cell Banking Service Segment by Type

Neonatal Immune Cell Storage

Adult Immune Cell Storage

Immune Cell Banking Service Segment by Application

Medical Scene

Non-medical Scene

Immune Cell Banking Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Cell Banking Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Cell Banking Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Cell Banking Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Immune Cell Banking Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Immune Cell Banking Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Cell Banking Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immune Cell Banking Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Neonatal Immune Cell Storage Major Player Table 3. Adult Immune Cell Storage Major Player Table 4. Global Immune Cell Banking Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Scene Major Player Table 6. Non-medical Scene Major Player Table 7. Immune Cell Banking Service Industry Trends Table 8. Immune Cell Banking Service Industry Drivers Table 9. Immune Cell Banking Service Industry Opportunities and Challenges Table 10. Immune Cell Banking Service Industry Restraints Table 11. Global Immune Cell Banking Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Immune Cell Banking Service Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Immune Cell Banking Service Market Share by Region (2021-2026) Table 14. Global Immune Cell Banking Service Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Immune Cell Banking Service Market Share by Region (2027-2032) Table 16. Global Immune Cell Banking Service Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Immune Cell Banking Service Revenue Market Share by Players (2021-2026) Table 18. Global Immune Cell Banking Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Immune Cell Banking Service Key Players Headquarters & Area Served Table 20. Global Immune Cell Banking Service Players, Product Type & Application Table 21. Global Immune Cell Banking Service Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Immune Cell Banking Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Immune Cell Banking Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Immune Cell Banking Service Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Immune Cell Banking Service Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Immune Cell Banking Service Revenue Market Share by Type (2021-2026) Table 28. Global Immune Cell Banking Service Revenue Market Share by Type (2027-2032) Table 29. Global Immune Cell Banking Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Immune Cell Banking Service Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Immune Cell Banking Service Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Immune Cell Banking Service Revenue Market Share by Application (2021-2026) Table 33. Global Immune Cell Banking Service Revenue Market Share by Application (2027-2032) Table 34. HealthBanks Company Information Table 35. HealthBanks Business Overview Table 36. HealthBanks Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. HealthBanks Immune Cell Banking Service Product Portfolio Table 38. HealthBanks Recent Development Table 39. BioLife Solutions Company Information Table 40. BioLife Solutions Business Overview Table 41. BioLife Solutions Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. BioLife Solutions Immune Cell Banking Service Product Portfolio Table 43. BioLife Solutions Recent Development Table 44. Sartorius Company Information Table 45. Sartorius Business Overview Table 46. Sartorius Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sartorius Immune Cell Banking Service Product Portfolio Table 48. Sartorius Recent Development Table 49. ThermoGenesis Company Information Table 50. ThermoGenesis Business Overview Table 51. ThermoGenesis Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. ThermoGenesis Immune Cell Banking Service Product Portfolio Table 53. ThermoGenesis Recent Development Table 54. Charles River Company Information Table 55. Charles River Business Overview Table 56. Charles River Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Charles River Immune Cell Banking Service Product Portfolio Table 58. Charles River Recent Development Table 59. Biorep Technologies Company Information Table 60. Biorep Technologies Business Overview Table 61. Biorep Technologies Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Biorep Technologies Immune Cell Banking Service Product Portfolio Table 63. Biorep Technologies Recent Development Table 64. Cryo-Cell International Company Information Table 65. Cryo-Cell International Business Overview Table 66. Cryo-Cell International Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Cryo-Cell International Immune Cell Banking Service Product Portfolio Table 68. Cryo-Cell International Recent Development Table 69. CGT GLOBAL Company Information Table 70. CGT GLOBAL Business Overview Table 71. CGT GLOBAL Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. CGT GLOBAL Immune Cell Banking Service Product Portfolio Table 73. CGT GLOBAL Recent Development Table 74. Cordlife Group Company Information Table 75. Cordlife Group Business Overview Table 76. Cordlife Group Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Cordlife Group Immune Cell Banking Service Product Portfolio Table 78. Cordlife Group Recent Development Table 79. Celularity Company Information Table 80. Celularity Business Overview Table 81. Celularity Immune Cell Banking Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Celularity Immune Cell Banking Service Product Portfolio Table 83. Celularity Recent Development Table 84. Boyalife Company Information Table 85. Boyalife Business Overview Table 86. Boyalife Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Boyalife Immune Cell Banking Service Product Portfolio Table 88. Boyalife Recent Development Table 89. Beike Biotechnology Company Information Table 90. Beike Biotechnology Business Overview Table 91. Beike Biotechnology Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Beike Biotechnology Immune Cell Banking Service Product Portfolio Table 93. Beike Biotechnology Recent Development Table 94. Forever Labs Company Information Table 95. Forever Labs Business Overview Table 96. Forever Labs Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Forever Labs Immune Cell Banking Service Product Portfolio Table 98. Forever Labs Recent Development Table 99. Redermis Company Information Table 100. Redermis Business Overview Table 101. Redermis Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Redermis Immune Cell Banking Service Product Portfolio Table 103. Redermis Recent Development Table 104. LifeCell International Company Information Table 105. LifeCell International Business Overview Table 106. LifeCell International Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. LifeCell International Immune Cell Banking Service Product Portfolio Table 108. LifeCell International Recent Development Table 109. VCANBIO Company Information Table 110. VCANBIO Business Overview Table 111. VCANBIO Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. VCANBIO Immune Cell Banking Service Product Portfolio Table 113. VCANBIO Recent Development Table 114. BGI Group Company Information Table 115. BGI Group Business Overview Table 116. BGI Group Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. BGI Group Immune Cell Banking Service Product Portfolio Table 118. BGI Group Recent Development Table 119. Shanghai Cell Therapy Group Company Information Table 120. Shanghai Cell Therapy Group Business Overview Table 121. Shanghai Cell Therapy Group Immune Cell Banking Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Shanghai Cell Therapy Group Immune Cell Banking Service Product Portfolio Table 123. Shanghai Cell Therapy Group Recent Development Table 124. North America Immune Cell Banking Service Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Immune Cell Banking Service Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Immune Cell Banking Service Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Immune Cell Banking Service Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Immune Cell Banking Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Immune Cell Banking Service Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Immune Cell Banking Service Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Immune Cell Banking Service Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Immune Cell Banking Service Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Immune Cell Banking Service Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Immune Cell Banking Service Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Immune Cell Banking Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Immune Cell Banking Service Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Immune Cell Banking Service Revenue by Country (US$ Million) & (2027-2032) Table 138. China Immune Cell Banking Service Revenue by Type (2021-2026) & (US$ Million) Table 139. China Immune Cell Banking Service Revenue by Type (2027-2032) & (US$ Million) Table 140. China Immune Cell Banking Service Revenue by Application (2021-2026) & (US$ Million) Table 141. China Immune Cell Banking Service Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Immune Cell Banking Service Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Immune Cell Banking Service Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Immune Cell Banking Service Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Immune Cell Banking Service Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Immune Cell Banking Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Immune Cell Banking Service Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Immune Cell Banking Service Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Immune Cell Banking Service Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Immune Cell Banking Service Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Immune Cell Banking Service Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Immune Cell Banking Service Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Immune Cell Banking Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Immune Cell Banking Service Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Immune Cell Banking Service Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Immune Cell Banking Service Image Figure 2. Global Immune Cell Banking Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Cell Banking Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Neonatal Immune Cell Storage Image Figure 5. Adult Immune Cell Storage Image Figure 6. Global Immune Cell Banking Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Immune Cell Banking Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Scene Image Figure 9. Non-medical Scene Image Figure 10. Global Immune Cell Banking Service Market Size (US$ Million) & (2021-2032) Figure 11. Global Immune Cell Banking Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Immune Cell Banking Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Immune Cell Banking Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Immune Cell Banking Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Immune Cell Banking Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Immune Cell Banking Service Revenue Market Share by Type (2021-2032) Figure 18. Global Immune Cell Banking Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Immune Cell Banking Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Immune Cell Banking Service Revenue Market Share by Application (2021-2032) Figure 21. North America Immune Cell Banking Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Immune Cell Banking Service Revenue Share by Type (2021-2032) Figure 23. North America Immune Cell Banking Service Revenue Share by Application (2021-2032) Figure 24. North America Immune Cell Banking Service Revenue Share by Country (2021-2032) Figure 25. United States Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Immune Cell Banking Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Immune Cell Banking Service Revenue Share by Type (2021-2032) Figure 30. Europe Immune Cell Banking Service Revenue Share by Application (2021-2032) Figure 31. Europe Immune Cell Banking Service Revenue Share by Country (2021-2032) Figure 32. Germany Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Immune Cell Banking Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Immune Cell Banking Service Revenue Share by Type (2021-2032) Figure 42. China Immune Cell Banking Service Revenue Share by Application (2021-2032) Figure 43. Asia Immune Cell Banking Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Immune Cell Banking Service Revenue Share by Type (2021-2032) Figure 45. Asia Immune Cell Banking Service Revenue Share by Application (2021-2032) Figure 46. Asia Immune Cell Banking Service Revenue Share by Region (2021-2032) Figure 47. Japan Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Immune Cell Banking Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Immune Cell Banking Service Revenue Share by Type (2021-2032) Figure 55. SAMEA Immune Cell Banking Service Revenue Share by Application (2021-2032) Figure 56. SAMEA Immune Cell Banking Service Revenue Share by Country (2021-2032) Figure 57. Brazil Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Immune Cell Banking Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Neonatal Immune Cell Storage
  • Adult Immune Cell Storage
Applications
  • Medical Scene
  • Non-medical Scene
Companies covered
  • HealthBanks
  • BioLife Solutions
  • Sartorius
  • ThermoGenesis
  • Charles River
  • Biorep Technologies
  • Cryo-Cell International
  • CGT GLOBAL
  • Cordlife Group
  • Celularity
  • Boyalife
  • Beike Biotechnology
  • Forever Labs
  • Redermis
  • LifeCell International
  • VCANBIO
  • BGI Group
  • Shanghai Cell Therapy Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immune Cell Banking Service Market by Type
  3. 1.2.1 Global Immune Cell Banking Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Neonatal Immune Cell Storage
  5. 1.2.3 Adult Immune Cell Storage
  6. 1.3 Immune Cell Banking Service Market by Application
  7. 1.3.1 Global Immune Cell Banking Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Scene
  9. 1.3.3 Non-medical Scene
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Immune Cell Banking Service Market Dynamics
  1. 2.1 Immune Cell Banking Service Industry Trends
  2. 2.2 Immune Cell Banking Service Industry Drivers
  3. 2.3 Immune Cell Banking Service Industry Opportunities and Challenges
  4. 2.4 Immune Cell Banking Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Immune Cell Banking Service Market Perspective (2021-2032)
  2. 3.2 Global Immune Cell Banking Service Growth Trends by Region
  3. 3.2.1 Global Immune Cell Banking Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immune Cell Banking Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Immune Cell Banking Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Immune Cell Banking Service Revenue by Players
  2. 4.1.1 Global Immune Cell Banking Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Immune Cell Banking Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Immune Cell Banking Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immune Cell Banking Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Immune Cell Banking Service Key Players Headquarters & Area Served
  7. 4.4 Global Immune Cell Banking Service Players, Product Type & Application
  8. 4.5 Global Immune Cell Banking Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Immune Cell Banking Service Market CR5 and HHI
  11. 4.6.3 2025 Immune Cell Banking Service Tier 1, Tier 2, and Tier 3
5 Immune Cell Banking Service Market Size by Type
  1. 5.1 Global Immune Cell Banking Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Immune Cell Banking Service Revenue by Type (2021-2032)
  3. 5.3 Global Immune Cell Banking Service Revenue Market Share by Type (2021-2032)
6 Immune Cell Banking Service Market Size by Application
  1. 6.1 Global Immune Cell Banking Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Immune Cell Banking Service Revenue by Application (2021-2032)
  3. 6.3 Global Immune Cell Banking Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 HealthBanks
  2. 7.1.1 HealthBanks Company Information
  3. 7.1.2 HealthBanks Business Overview
  4. 7.1.3 HealthBanks Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 HealthBanks Immune Cell Banking Service Product Portfolio
  6. 7.1.5 HealthBanks Recent Developments
  7. 7.2 BioLife Solutions
  8. 7.2.1 BioLife Solutions Company Information
  9. 7.2.2 BioLife Solutions Business Overview
  10. 7.2.3 BioLife Solutions Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioLife Solutions Immune Cell Banking Service Product Portfolio
  12. 7.2.5 BioLife Solutions Recent Developments
  13. 7.3 Sartorius
  14. 7.3.1 Sartorius Company Information
  15. 7.3.2 Sartorius Business Overview
  16. 7.3.3 Sartorius Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sartorius Immune Cell Banking Service Product Portfolio
  18. 7.3.5 Sartorius Recent Developments
  19. 7.4 ThermoGenesis
  20. 7.4.1 ThermoGenesis Company Information
  21. 7.4.2 ThermoGenesis Business Overview
  22. 7.4.3 ThermoGenesis Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ThermoGenesis Immune Cell Banking Service Product Portfolio
  24. 7.4.5 ThermoGenesis Recent Developments
  25. 7.5 Charles River
  26. 7.5.1 Charles River Company Information
  27. 7.5.2 Charles River Business Overview
  28. 7.5.3 Charles River Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Charles River Immune Cell Banking Service Product Portfolio
  30. 7.5.5 Charles River Recent Developments
  31. 7.6 Biorep Technologies
  32. 7.6.1 Biorep Technologies Company Information
  33. 7.6.2 Biorep Technologies Business Overview
  34. 7.6.3 Biorep Technologies Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biorep Technologies Immune Cell Banking Service Product Portfolio
  36. 7.6.5 Biorep Technologies Recent Developments
  37. 7.7 Cryo-Cell International
  38. 7.7.1 Cryo-Cell International Company Information
  39. 7.7.2 Cryo-Cell International Business Overview
  40. 7.7.3 Cryo-Cell International Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cryo-Cell International Immune Cell Banking Service Product Portfolio
  42. 7.7.5 Cryo-Cell International Recent Developments
  43. 7.8 CGT GLOBAL
  44. 7.8.1 CGT GLOBAL Company Information
  45. 7.8.2 CGT GLOBAL Business Overview
  46. 7.8.3 CGT GLOBAL Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CGT GLOBAL Immune Cell Banking Service Product Portfolio
  48. 7.8.5 CGT GLOBAL Recent Developments
  49. 7.9 Cordlife Group
  50. 7.9.1 Cordlife Group Company Information
  51. 7.9.2 Cordlife Group Business Overview
  52. 7.9.3 Cordlife Group Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Cordlife Group Immune Cell Banking Service Product Portfolio
  54. 7.9.5 Cordlife Group Recent Developments
  55. 7.10 Celularity
  56. 7.10.1 Celularity Company Information
  57. 7.10.2 Celularity Business Overview
  58. 7.10.3 Celularity Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Celularity Immune Cell Banking Service Product Portfolio
  60. 7.10.5 Celularity Recent Developments
  61. 7.11 Boyalife
  62. 7.11.1 Boyalife Company Information
  63. 7.11.2 Boyalife Business Overview
  64. 7.11.3 Boyalife Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Boyalife Immune Cell Banking Service Product Portfolio
  66. 7.11.5 Boyalife Recent Developments
  67. 7.12 Beike Biotechnology
  68. 7.12.1 Beike Biotechnology Company Information
  69. 7.12.2 Beike Biotechnology Business Overview
  70. 7.12.3 Beike Biotechnology Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Beike Biotechnology Immune Cell Banking Service Product Portfolio
  72. 7.12.5 Beike Biotechnology Recent Developments
  73. 7.13 Forever Labs
  74. 7.13.1 Forever Labs Company Information
  75. 7.13.2 Forever Labs Business Overview
  76. 7.13.3 Forever Labs Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Forever Labs Immune Cell Banking Service Product Portfolio
  78. 7.13.5 Forever Labs Recent Developments
  79. 7.14 Redermis
  80. 7.14.1 Redermis Company Information
  81. 7.14.2 Redermis Business Overview
  82. 7.14.3 Redermis Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Redermis Immune Cell Banking Service Product Portfolio
  84. 7.14.5 Redermis Recent Developments
  85. 7.15 LifeCell International
  86. 7.15.1 LifeCell International Company Information
  87. 7.15.2 LifeCell International Business Overview
  88. 7.15.3 LifeCell International Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 LifeCell International Immune Cell Banking Service Product Portfolio
  90. 7.15.5 LifeCell International Recent Developments
  91. 7.16 VCANBIO
  92. 7.16.1 VCANBIO Company Information
  93. 7.16.2 VCANBIO Business Overview
  94. 7.16.3 VCANBIO Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 VCANBIO Immune Cell Banking Service Product Portfolio
  96. 7.16.5 VCANBIO Recent Developments
  97. 7.17 BGI Group
  98. 7.17.1 BGI Group Company Information
  99. 7.17.2 BGI Group Business Overview
  100. 7.17.3 BGI Group Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 BGI Group Immune Cell Banking Service Product Portfolio
  102. 7.17.5 BGI Group Recent Developments
  103. 7.18 Shanghai Cell Therapy Group
  104. 7.18.1 Shanghai Cell Therapy Group Company Information
  105. 7.18.2 Shanghai Cell Therapy Group Business Overview
  106. 7.18.3 Shanghai Cell Therapy Group Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Shanghai Cell Therapy Group Immune Cell Banking Service Product Portfolio
  108. 7.18.5 Shanghai Cell Therapy Group Recent Developments
8 North America
  1. 8.1 North America Immune Cell Banking Service Revenue (2021-2032)
  2. 8.2 North America Immune Cell Banking Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Immune Cell Banking Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Immune Cell Banking Service Revenue by Type (2027-2032)
  5. 8.3 North America Immune Cell Banking Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Immune Cell Banking Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Immune Cell Banking Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Immune Cell Banking Service Revenue by Application (2027-2032)
  9. 8.5 North America Immune Cell Banking Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Immune Cell Banking Service Revenue by Country
  11. 8.6.1 North America Immune Cell Banking Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Immune Cell Banking Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Immune Cell Banking Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Immune Cell Banking Service Revenue (2021-2032)
  2. 9.2 Europe Immune Cell Banking Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Immune Cell Banking Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Immune Cell Banking Service Revenue by Type (2027-2032)
  5. 9.3 Europe Immune Cell Banking Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Immune Cell Banking Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Immune Cell Banking Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Immune Cell Banking Service Revenue by Application (2027-2032)
  9. 9.5 Europe Immune Cell Banking Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Immune Cell Banking Service Revenue by Country
  11. 9.6.1 Europe Immune Cell Banking Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Immune Cell Banking Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Immune Cell Banking Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Immune Cell Banking Service Revenue (2021-2032)
  2. 10.2 China Immune Cell Banking Service Revenue by Type (2021-2032)
  3. 10.2.1 China Immune Cell Banking Service Revenue by Type (2021-2026)
  4. 10.2.2 China Immune Cell Banking Service Revenue by Type (2027-2032)
  5. 10.3 China Immune Cell Banking Service Revenue Share by Type (2021-2032)
  6. 10.4 China Immune Cell Banking Service Revenue by Application (2021-2032)
  7. 10.4.1 China Immune Cell Banking Service Revenue by Application (2021-2026)
  8. 10.4.2 China Immune Cell Banking Service Revenue by Application (2027-2032)
  9. 10.5 China Immune Cell Banking Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immune Cell Banking Service Revenue (2021-2032)
  2. 11.2 Asia Immune Cell Banking Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Immune Cell Banking Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Immune Cell Banking Service Revenue by Type (2027-2032)
  5. 11.3 Asia Immune Cell Banking Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Immune Cell Banking Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Immune Cell Banking Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Immune Cell Banking Service Revenue by Application (2027-2032)
  9. 11.5 Asia Immune Cell Banking Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Immune Cell Banking Service Revenue by Country
  11. 11.6.1 Asia Immune Cell Banking Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Immune Cell Banking Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Immune Cell Banking Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immune Cell Banking Service Revenue (2021-2032)
  2. 12.2 SAMEA Immune Cell Banking Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Immune Cell Banking Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Immune Cell Banking Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Immune Cell Banking Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Immune Cell Banking Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Immune Cell Banking Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Immune Cell Banking Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Immune Cell Banking Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Immune Cell Banking Service Revenue by Country
  11. 12.6.1 SAMEA Immune Cell Banking Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Immune Cell Banking Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Immune Cell Banking Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst